Dear Valued Partners,

Greetings from the Raphas ODM Sales Team!

As August swiftly passes and we step into September, the final quarter of 2025 is approaching.

Despite the lingering summer heat, we hope you are doing well.

Looking ahead to the upcoming year, we invite you to explore new opportunities with Raphas,

a global leader in microneedle innovation, to expand into promising new markets.

1. Scientifically Proven Superior Absorption

In a recent joint study with our ODM partner in Japan,

Raphas successfully visualized the delivery of active ingredients

from our microneedle patches into the skin using 3D laser microscopy.

(Left: Topical Solution Application / Right: Microneedle Application)

(Presented at the 41st Annual Meeting of the Japanese DDS Society – Awarded for Outstanding Presentation)

Compared to the same ingredient applied as a topical solution,

microneedle delivery penetrated far deeper than the skin surface.

Today, simply using premium ingredients is no longer enough.

The key lies in how precisely and effectively these actives reach their target area.



With Raphas’ advanced dissolving microneedle technology,

your products can go beyond the limitations of conventional cosmetics,

ensuring exceptional absorption and stability.



Take your product line to the next level with cutting-edge transdermal delivery solutions.

2. Proven Excellence – 5-Time Olive Young Award Winner

Our flagship product, Acropass Trouble Cure, has been awarded

in the Spot Patch category at Olive Young Awards for five consecutive years (2020–2024).

Olive Young is the largest beauty retail platform in Korea,

and this recognition reflects unmatched quality and strong consumer trust in Raphas products.

Leveraging this expertise, Raphas currently supplies over

60% of all microneedle patches sold at Olive Young.

But we don’t stop there. We continue to innovate—

refining formulations, patch designs, raw materials, and packaging—

to deliver superior efficacy and customer satisfaction.



As the pioneer that first commercialized the DEN Microneedle Technology,

Raphas is rapidly gaining global recognition for safety, efficacy, and convenience.

Partner with us to add innovative solutions and fresh insights to your portfolio.

3. World-Class Manufacturing with Full Certification

Raphas provides microneedle solutions with proven safety and consistency,

backed by global quality standards and extensive data.



Our in-house production facilities are certified under Korean CGMP and U.S. FDA MoCRA,

and we hold Korean MFDS pharmaceutical manufacturing approval.

All production is strictly managed under ISO 22716 guidelines, ensuring top-tier quality

from manufacturing to final packaging in fully certified environments.

This robust manufacturing capability guarantees that your products can achieve

global market competitiveness with confidence and compliance.

At Raphas, we go beyond being a supplier—

we are your strategic partner throughout the entire process,

from planning and development to certification and production.



Let us help you turn your ideas into reality and secure

a distinct competitive edge in the global beauty market.

We look forward to discussing how we can work together.

Thank you.

Raphas ODM Sales Team